The European Union
Biocidal Products Regulation dramatically changes the way biocidal active
substances and products, as well as many products not traditionally considered
biocidal products, are regulated under European law. Practical aspects of this new
regulatory system are subtly different from those in other jurisdictions, EU
neighboring countries, and the U.S.
to the EU as a component of their global business must ensure that their supply
chains and product designs are compliant with the regulation.
The webinar will
focus on existing industry norms and explore how current standard practices
will be affected by the new developments in EU biocides regulation. The current
trends in the EU biocides regulatory landscape will be compared to the U.S.
system (the Federal Insecticide, Fungicide, and Rodenticide Act), and the time
and practical steps necessary to bring a product to market in the U.S. and EU
will be contrasted.
Would Benefit From Attending This Program:
attorneys, environmental consultants, product stewardship managers, regulatory
compliance managers, marketing and business development managers, and companies
exporting biocidal substances and products to the EU.
understanding of environmental and/or natural resource law.
CPE Delivery method:
Field of Study:
Knowledge & Applications
1.5 credits (may vary based on locations requested)
easily and securely
to reserve your space now for Bloomberg BNA's upcoming
EHS Webinar and get a $75
discount as a Bloomberg BNA subscriber! Or, call 800-372-1033, menu Option 6, submenu
Option 1, and refer to the date and title of this conference.
Lines are open from 8:30
a.m. to 7:00 p.m. ET, excluding most federal holidays.
In addition, you’ll receive:
. Once you’ve
registered, send your questions in advance to email@example.com and they’ll be
included in the program. You’ll also have a chance to ask your questions during
. You need no
materials upfront to follow along to our live conference. But Bloomberg BNA
always issues a follow-up e-mail with contact information for our speakers as
well as other materials related to the topic.
CLE and CPE credits will be available
for this EHS
Andrew R. Bourne, Lisa R. Burchi, Lara A. Hall
Andrew R. Bourne
is a regulatory specialist
working in U.K. offices of The Acta Group, Bergeson & Campbell, P.C.'s
consulting affiliate, and focusing on European biocidal and plant protection
issues. He has expertise in testing
and consultation environments,
as well as practical expertise in both environmental modeling and monitoring.
Andrew focuses on regulatory compliance for industrial chemicals, biocidal products/substances
and fertilizers. He provides guidance in environmental and human health risk
assessment, and product classification, labeling, and safety; as well as
regulatory advice in EU Registration, Evaluation, Authorization and Restriction
of Chemicals issues, biocides product regulation, and globally harmonized system
of classification and labeling.
Lisa R. Burchi is of
counsel to Bergeson & Campbell P.C., and works extensively in Toxic
Substances Control Act and the Federal Insecticide, Fungicide and Rodenticide Act
regulatory matters. She has particular expertise in data compensation matters,
and also counsels on matters related to California law, including Proposition
65 and the recent green chemistry initiative/safer consumer products regulations.
She delivers more than 15 years of experience in highly specialized fields.
Prior to attending law school and joining Bergeson & Campbell P.C, Lisa
worked as a nominations clerk for the Senate Judiciary Committee. She is
admitted to the California and District of Columbia bars.
Lara A. Hall
staff scientist with Bergeson & Campbell, P.C., with significant expertise
in E.U. biocides and U.S. pesticide submissions, and is a registered quality assurance
professional in good laboratory practices with over a decade of experience in environmental
research, study monitoring, and international regulatory support. Lara aids
clients in placing and monitoring studies to assist with new chemicals,
pesticides, biocides, and endocrine disruptor testing programs; developing
testing plans for chemicals seeking regulatory approval; and assessing studies
for conformance with testing guidelines, data compensation, and regulatory and
good laboratory practices requirements.